156 related articles for article (PubMed ID: 1251316)
1. Immunostimulation with intraperitoneally administered bacille Calmette Guérin for advanced malignant tumors of the gastrointestinal tract.
Falk RE; MacGregor AB; Landi S; Ambus U; Langer B
Surg Gynecol Obstet; 1976 Mar; 142(3):363-8. PubMed ID: 1251316
[TBL] [Abstract][Full Text] [Related]
2. Nonspecific and selective stimulation of the immune system in the treatment of carcinoma in humans.
Falk RE; Makowka L; Ambus U; Falk JA; Bugala R; Landi S
Can Med Assoc J; 1983 Jun; 128(12):1385-8, 1422. PubMed ID: 6850464
[TBL] [Abstract][Full Text] [Related]
3. Palliative management of advanced carcinoma of the gastrointestinal tract.
Cady B
Surg Clin North Am; 1971 Jun; 51(3):761-73. PubMed ID: 4102948
[No Abstract] [Full Text] [Related]
4. Oral bacille Calmette Guérin immunostimulation in malignant melanoma.
MacGregor AB; Falk RE; Landi S; Ambus U; Langer B
Surg Gynecol Obstet; 1975 Nov; 141(5):747-54. PubMed ID: 1105837
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant immunostimulation in malignant melanoma with oral Bacille Calmette-Guérin.
MacGregor AB; Falk RE; Landi S; Ambus U; Samuel ES; Langer B
Can J Surg; 1977 Jan; 20(1):25-30. PubMed ID: 832200
[TBL] [Abstract][Full Text] [Related]
6. Lesser sac endoscopy and laparoscopy in pancreatic carcinoma definitive diagnosis, staging and palliation.
Charukhchyan SA; Lucas GW
Am Surg; 1998 Sep; 64(9):809-14; discussion 814-6. PubMed ID: 9731805
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant chemoimmunotherapy for gastric carcinoma.
Makowka L; Falk RE; Ambus U; Bugala R; Landi S
Can J Surg; 1980 Sep; 23(5):429-31. PubMed ID: 6159957
[TBL] [Abstract][Full Text] [Related]
8. Management of esophageal, gastric, pancreatic, and hepatobiliary neoplasms.
Bleiberg H
Curr Opin Oncol; 1991 Aug; 3(4):737-44. PubMed ID: 1657205
[TBL] [Abstract][Full Text] [Related]
9. Management of gastrointestinal cancer.
Heal JM; Schein PS
Med Clin North Am; 1977 Sep; 61(5):991-9. PubMed ID: 330979
[No Abstract] [Full Text] [Related]
10. Long-term effects of bacille Calmette-Guérin perfusion therapy for treatment of transitional cell carcinoma in situ of upper urinary tract.
Hayashida Y; Nomata K; Noguchi M; Eguchi J; Koga S; Yamashita S; Hayashi M; Kanatake H
Urology; 2004 Jun; 63(6):1084-8. PubMed ID: 15183955
[TBL] [Abstract][Full Text] [Related]
11. [The neoadjuvant treatment of gastrointestinal tumors: time for rethinking?].
Ebert MP; Schmid RM
Dtsch Med Wochenschr; 2009 Sep; 134(37):1835-7. PubMed ID: 19728255
[No Abstract] [Full Text] [Related]
12. [Prevention of immunodeficiency induced by cancer chemotherapy with BCG].
Miyata T; Masuda H; Inoue T; Saeki K; Torisu M
Gan To Kagaku Ryoho; 1988 Feb; 15(2):297-300. PubMed ID: 3341790
[TBL] [Abstract][Full Text] [Related]
13. Serum alpha-fetoprotein in patients with neoplasms of the gastrointestinal tract.
McIntire KR; Waldmann TA; Moertel CG; Go VL
Cancer Res; 1975 Apr; 35(4):991-6. PubMed ID: 46783
[TBL] [Abstract][Full Text] [Related]
14. Update on the Dutch Cooperative Trial: mitomycin versus bacillus Calmette-Guérin-Tice versus bacillus Calmette-Guérin RIVM in the treatment of patients with pTA-pT1 papillary carcinoma and carcinoma in situ of the urinary bladder. Dutch South East Cooperative Urological Group.
Witjes WP; Witjes JA; Oosterhof GO; Debruyne MJ
Semin Urol Oncol; 1996 Feb; 14(1 Suppl 1):10-6. PubMed ID: 8727805
[TBL] [Abstract][Full Text] [Related]
15. Randomized comparison of melphalan and 5-fluorouracil in the treatment of advanced gastrointestinal cancer.
Bullen BR; Giles GR; Malhotra A; Bird GG; Hall R; Bunch GA; Brown GJ
Cancer Treat Rep; 1976 Sep; 60(9):1267-71. PubMed ID: 797448
[No Abstract] [Full Text] [Related]
16. Immunotherapy of human solid tumors with Bacillus Calmette-Guérin: prolongation of disease-free interval and survival in malignant melanoma, breast, and colorectal cancer.
Gutterman JU; Mavligit GM; Blumenshein G; Burgess MA; McBride CM; Hersh EM
Ann N Y Acad Sci; 1976; 277(00):135-59. PubMed ID: 1069546
[No Abstract] [Full Text] [Related]
17. Combined treatment with BCG and chemotherapy for metastatic gastrointestinal cancer.
Falk RE; MacGregor AB; Ambus U; Landi S; Miller AB; Samuel ES; Langer B
Dis Colon Rectum; 1977 Apr; 20(3):215-22. PubMed ID: 849691
[TBL] [Abstract][Full Text] [Related]
18. A controlled clinical and immunological evaluation of immunotherapy with Bacillus Calmette--Guerin in patients with metastatic cancer.
O'Connell MJ; Ritts RE; Moertel CG; O'Fallon JR; Rubin J; Frytak S; Schutt AJ
Cancer Clin Trials; 1981; 4(4):439-49. PubMed ID: 6459190
[TBL] [Abstract][Full Text] [Related]
19. [Current state of therapy for gastrointestinal tumors].
Hartmann D; Obrecht JP
Schweiz Med Wochenschr; 1978 Sep; 108(35):1373-7. PubMed ID: 684400
[TBL] [Abstract][Full Text] [Related]
20. Initial trial use of murine monoclonal antibodies as immunotherapeutic agents for gastrointestinal adenocarcinoma.
Sears HF; Herlyn D; Steplewski Z; Koprowski H
Hybridoma; 1986 Jul; 5 Suppl 1():S109-15. PubMed ID: 3488949
[No Abstract] [Full Text] [Related]
[Next] [New Search]
